Ophysio Inc.
Miami, United States · Founded 2015
- Headquarters
- Miami, Florida
- Employees
- 1–10
- Founded
- 2015
About
Ophysio Inc. is an R&D company developing technology to grow insulin-producing cells from pancreatic tissue discarded during islet transplantation, using precise oxygen control combined with an FDA-approved growth factor (BMP-7) to treat type 1 diabetes. Based in Miami and working with University of Miami collaborators, the company has received multiple SBIR/STTR awards from NIH to advance this cell therapy platform.
Summary
Ophysio Inc. is a Biotech company based in Miami, United States, founded in 2015.
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/ophysio-inc"><img src="https://indexed.vc/api/badge/company/ophysio-inc" alt="Ophysio Inc. on Indexed.vc" width="260" height="76" /></a>